Skip to main content
Autobound logo
WatersIn development

Waters, IMU Biosciences partner on immune profiling applications.

Read at genomeweb.com

What happened

Waters Corporation is developing artificial intelligence-powered immune profiling platform on Jun 24th '26.

Source

genomeweb.comJun 24, 2026

Waters, IMU Biosciences partner on immune profiling applications.

Article excerpt

Highlighted: the sentence this signal was extracted from

Waters, IMU Biosciences partner on immune profiling applications. NEW YORK - Waters and IMU Biosciences said Wednesday that they have entered a strategic partnership to develop IMU's artificial intelligence-powered immune profiling platform. Get the full story with GenomeWeb Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month Already a GenomeWeb member? LoginLogin

genomeweb.com/cancer/waters-imu-biosciences-partner-immune-profiling-...Read the full source

Extracted by Autobound

From the Signal API record
Event
In development

What this signalsWork in development often leads to new buying for tools, data and services.

Takes effect
Jun 24, 2026
Location
New York, New York, United States

More from Waters

Company page →

More in development signals at other companies

The full record

From the Signal API record

Details

Ticker
NYSE:WAT
Product
artificial intelligence-powered immune profiling platform

Topics and mentions

Asset tags

  • research and development

Product tags

  • online technology
  • general technology
  • future tech

Job title tags

  • general technology
  • data analysis

Extraction

Confidence
89%
Detected
Jun 24, 2026
signal_type
news
signal_subtype
is_developing

Use this data

Get every in development signal for Waters and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Waters this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns in development signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/efb47beb-f7ab-4f1b-8b62-69c1c990fa7a returns this record as JSON. POST /v1/companies/enrich returns every signal for waters.com.

{
  "signal_id": "efb47beb-f7ab-4f1b-8b62-69c1c990fa7a",
  "signal_type": "news",
  "signal_subtype": "is_developing",
  "detected_at": "2026-06-24T14:21:15+00:00",
  "company": {
    "name": "Waters",
    "domain": "waters.com"
  },
  "data": {
    "url": "https://www.genomeweb.com/cancer/waters-imu-biosciences-partner-immune-profiling-applications",
    "title": "Waters, IMU Biosciences partner on immune profiling applications.",
    "ticker": "NYSE:WAT",
    "excerpt": "Waters, IMU Biosciences partner on immune profiling applications.\n\nNEW YORK - Waters and IMU Biosciences said Wednesday that they have entered a strategic partnership to develop IMU's artificial intelligence-powered immune profiling platform.\n\nGet the full story with GenomeWeb Premium.\n\nOnly $95 for the first 90 days.\n\nFull site access\n\nInterest-based email alerts\n\nPremium Access - Trial Offer\n\n$95.00 for 3 month\n\nAlready a GenomeWeb member? LoginLogin",
    "product": "artificial intelligence-powered immune profiling platform",
    "summary": "Waters Corporation is developing artificial intelligence-powered immune profiling platform on Jun 24th '26.",
    "location": "New York, New York, United States, Northern America, Americas",
    "planning": false,
    "image_url": "https://crain-platform-genomeweb-prod.s3.amazonaws.com/s3fs-public/logo.svg",
    "confidence": 0.8882,
    "assets_tags": [
      "research_and_development"
    ],
    "product_data": {
      "full_text": "artificial intelligence-powered immune profiling platform",
      "fuzzy_match": true
    },
    "product_tags": [
      "online_technology",
      "general_technology",
      "future_tech"
    ],
    "published_at": "2026-06-24T14:21:15Z",
    "location_data": [
      {
        "city": "New York",
        "state": "New York",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-24",
    "job_title_tags": [
      "general_technology",
      "data_analysis"
    ],
    "article_sentence": "NEW YORK - Waters and IMU Biosciences said Wednesday that they have entered a strategic partnership to develop IMU's artificial intelligence-powered immune profiling platform."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.